Published Ahead-of-Print - Last Updated: March 14, 2017

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only

A nomogram to predict 5-fluorouracil toxicity: when pharmacogenomics meets the patient.

Botticelli, Andrea; Onesti, Concetta E.; Strigari, Lidia; More

Anti-Cancer Drugs ., Post Author Corrections: March 14, 2017

Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.

Dipasquale, Mariachiara; Murgia, Viviana; Veccia, Antonello; More

Anti-Cancer Drugs ., Post Author Corrections: March 1, 2017


PDF Only

Adriamycin in combination with dexamethasone and octreotide lacks activity on the treatment of a 4T1 metastatic breast cancer model.

Dalezis, Panayiotis; Trafalis, Dimitrios T.; Geromichalos, George D.; More

Anti-Cancer Drugs ., Post Author Corrections: March 7, 2017


PDF Only

Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib.

Ariyasu, Ryo; Horiike, Atsushi; Koyama, Junji; More

Anti-Cancer Drugs ., Post Author Corrections: February 20, 2017


PDF Only

Prognostic factors and outcome of patients with hematological malignancies in phase I trials: the Gustave Roussy scoring system.

Benajiba, Lina; Michot, Jean-Marie; Baldini, Capucine; More

Anti-Cancer Drugs ., Post Author Corrections: February 20, 2017


PDF Only